Maropitant Citrate Tablets 16, 24, 60 and 160 mg

of the Responsible Party

Revision date : 2024-05-06

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS05 GHS09
Health risk rating 3
Safety risk rating 1
Environmental risk rating 5

General Information

Version

.00

Revision date

2024-05-06

Product name

Maropitant Citrate Tablets 16, 24, 60 and 160 mg

1.2.1 Relevant identified uses

Maropitant Citrate tablets are indicated for the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs

Emergency telephone

1-833-571-1525

Icons in SDS

M009 M010 M011 M017 M059 GHS05 GHS09

Company Information

company name

of the Responsible Party

Section 2

SECTION 2: Hazards identification

Classification (GHS-US) Classification of the Substance or Mixture Classification (GHS-US) This product is a drug, as defined by the US Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.). It is in solid, final form for direct administration to the patient. Therefore, it is exempt from the US 2012 Hazard Communication Standard, as defined in the 29 CFR 1910.1200(b)(6)(vii)

2.2 Label elements

Physical hazard is not classified. However, it is serious hazards for eye damage/eye irritation, Specific target organ toxicity, Hazardous to the aquatic environment, Signal word is danger.

2.3 Other hazards

Causes serious eye damage. May cause damage to organs (cardiovascular system, liver) through prolonged or repeated exposure. Toxic to aquatic life with long lasting effects.

Ingredient(s) with unknown acute toxicity

Individuals with cardiac conditions may be more susceptible to toxicity in cases of overexposure.

2.1 Classification of the substance or mixture

Classification (GHS-US) This product is a drug, as defined by the US Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.). It is in solid, final form for direct administration to the patient. Therefore, it is exempt from the US 2012 Hazard Communication Standard, as defined in the 29 CFR 1910.1200(b)(6)(vii).

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.